Cargando…
Systemic treatments for thymic tumors: a narrative review
Thymic epithelial tumours (TETs) are rare tumours originating from the thymus. Considering the rarity of this disease, the management of TETs is still challenging and difficult. In fact, all the worldwide clinical practice guidelines are based on data from retrospective analyses, prospective single...
Autores principales: | Zucali, Paolo Andrea, De Vincenzo, Fabio, Perrino, Matteo, Digiacomo, Nunzio, Cordua, Nadia, D’Antonio, Federica, Borea, Federica, Santoro, Armando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794302/ https://www.ncbi.nlm.nih.gov/pubmed/35118329 http://dx.doi.org/10.21037/med-21-11 |
Ejemplares similares
-
Current Perspectives on Immunotherapy in the Peri-Operative Setting of Muscle-Infiltrating Bladder Cancer
por: Zucali, Paolo Andrea, et al.
Publicado: (2020) -
Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress
por: Perrino, Matteo, et al.
Publicado: (2023) -
Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
por: Borea, Federica, et al.
Publicado: (2023) -
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis
por: Giugliano, Federica, et al.
Publicado: (2022) -
Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature
por: Asselta, Rosanna, et al.
Publicado: (2021)